Últimas noticias sobre Docusign (NASDAQ:DOCU) Bolsa

DOCUSIGN INC

DocuSign

Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.

DocuSign.How-it-Works_2020_thumb_Update

News

Movers

DOCU

DocuSign sorprende con un sólido informe financiero y una nueva plataforma de IA. Analistas ajustan sus pronósticos.

Acciones de DocuSign (DOCU) suben un 17,9% tras superar expectativas: ¿seguirá la tendencia alcista?

Movers_Stocks

AAOI

AFYA

AKBA

BTBT

CVNA

FUTU

GDOT

QBTS

RBRK

RDUS

RGNX

RGTI

SMTC

SOUN

ULTA

Semtech sorprendió al mercado con ingresos y ganancias superiores a lo esperado. Inversores reaccionan ante este sólido desempeño trimestral.

Semtech, Rubrik, DocuSign, PagerDuty y otras acciones estadounidenses que suben el viernes

UltaBeautyGreenwood,,Indiana, - ,United,States,-,June,16,2020:,Beauty

Earnings

Pre-Market Outlook

Markets

Trading Ideas

Evaluamos las empresas que podrían captar la atención de los inversores hoy: Li Auto, RLX Technology, DocuSign, Ulta Beauty y The Buckle.

Acciones a seguir hoy en Wall Street: LI, RLX, DOCU, ULTA y BKE

Docusign Inc

Biotech

General

RADX

UPDATE: Radiopharm Theranostics Advances Toward IND Filing And 4Q25 Phase 1 Launch For RV01 Radiopharmaceutical Therapy After Preclinical Data Confirms RV01 Maintained High Tumour Uptake

RBC Capital analyst Michael Siperco assumes OceanaGold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/OGC#TSX">OGC</a>) with a Outperform rating and announces Price Target of C$8.

Price Target

Initiation

Analyst Ratings

TSX:OGC

RBC Capital Assumes OceanaGold at Outperform, Announces Price Target of C$8

Landmark industry collaboration maps threat actor aliases across vendors to accelerate response and strengthen global cyberdefense
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crowdstrike.com%2Fen-us%2F&amp;esheet=54263673&amp;newsitemid=20250602497894&amp;lan=en-US&amp;anchor=CrowdStrike&amp;index=1&amp;md5=323144393bfa3c05c58631682889cd19">CrowdStrike</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) and Microsoft today announced a collaboration to bring clarity and coordination to how cyber threat actors are identified and tracked across security vendors. By mapping threat actor aliases and aligning adversary attribution across platforms, the collaboration minimizes confusion caused by different naming systems and accelerates cyber defenders' response against today's and tomorrow's most sophisticated adversaries.

CRWD

CrowdStrike And Microsoft Collaborate To Standardize Adversary Attribution Across Platforms

RBC Capital analyst Michael Siperco assumes K92 Mining (TSX:<a class="ticker" href="https://www.benzinga.com/stock/KNT#TSX">KNT</a>) with a Outperform rating and announces Price Target of C$18.

TSX:KNT

RBC Capital Assumes K92 Mining at Outperform, Announces Price Target of C$18

Roper Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NYSE">ROP</a>) short percent of float has risen 6.54% since its last report. The company recently reported that it has 1.74 million shares sold short, which is 1.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.2 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Roper Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748880031_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Roper Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Roper Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Roper Technologies's peer group average for short interest as a percentage of float is 3.12%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What's Driving the Market Sentiment Around Roper Technologies?

WIIM

Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.

TJX Companies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) short percent of float has fallen 3.79% since its last report. The company recently reported that it has 14.32 million shares sold short, which is 1.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.97 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>TJX Companies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748880025_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for TJX Companies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing TJX Companies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, TJX Companies's peer group average for short interest as a percentage of float is 14.91%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About TJX Companies?

Adobe's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NYSE">ADBE</a>) short percent of float has risen 3.62% since its last report. The company recently reported that it has 9.76 million shares sold short, which is 2.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.76 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Adobe Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748880020_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Adobe has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Adobe's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Adobe's peer group average for short interest as a percentage of float is 3.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ADBE

Looking Into Adobe's Recent Short Interest

Looking into the current session, CRH Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) shares are trading at $90.66, after a 0.55% drop. Over the past month, the stock fell by 3.85%, but over the past year, it actually increased by 17.44%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1748880020_0_0.png" alt="Past Year Chart" />

<h3>How Does CRH P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
CRH has a lower P/E than the aggregate P/E of 21.65 of the Construction Materials industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748880020_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: CRH

Crocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) has outperformed the market over the past 15 years by 5.04% on an annualized basis producing an average annual return of 17.11%. Currently, Crocs has a market capitalization of $5.71 billion. 
Buying $1000 In CROX: If an investor had bought $1000 of CROX stock 15 years ago, it would be worth $10,715.79 today based on a price of $101.80 for CROX at the time of writing.
<h3>Crocs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748880015_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CROX

Here's How Much You Would Have Made Owning Crocs Stock In The Last 15 Years

Shaquille O&#8217;Neal is a Hall of Famer and one of the most dominant NBA players in history, but even he had moments early in his career where he struggled to handle the spotlight. One of those moments resulted in a life lesson from his late stepfather that would stay with him forever.
<h2 class="wp-block-heading">A Lesson In Perspective</h2>
After a rough game against the New York Knicks during his rookie season with the Orlando Magic, O&#8217;Neal felt overwhelmed. &#8220;I let the pressure get to me,&#8221; he recalled in a 2024 <a href="https://www.youtube.com/watch?v=OgPUs9royFc">interview</a>. His stepfather, the late Army drill sergeant Phillip Harrison, wasn't having it.
He called his son and told him to come home immediately. &#8220;Be here tomorrow at 0500 a.m.,&#8221; Harrison instructed. &#8220;Yes, sir,&#8221; Shaq replied.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
Shaq showed up on time the next morning, and they drove in silence. When O&#8217;Neal spoke, his stepfather snapped, clearly <a href="https://www.benzinga.com/personal-finance/25/01/42953411/nba-star-shaq-learned-true-meaning-of-pressure-after-his-dad-took-him-to-a-homeless-family-he-paid-36000-to-get-them-off-the-streets">angry that Shaq had let pressure get to him</a>. As they drove under a bridge, they saw a homeless family sleeping in a tent. They waited in the car, silently, for more than an hour as the family slowly woke up — first the man, then his wife, and finally two young children.&nbsp;
&#8220;He said, &#8216;What happened to the game yesterday?&#8217; I said, &#8216;Man, I don&#8217;t know. I let the pressure get to me.'&#8221; Harrison then gave it to him straight: &#8220;That&#8217;s pressure. Pressure is when you don&#8217;t know when your next meal is coming from.&#8221;
O&#8217;Neal retold the same story in a recent <a href="https://www.youtube.com/watch?v=gsraQqbPjl0">interview</a> on &#8220;The Tonight Show Starring Jimmy Fallon,&#8221; where he emphasized his stepfather&#8217;s frustration with athletes who complain. Harrison had said, &#8220;I&#8217;m tired of you spoiled, rich athletes making all this money who don&#8217;t perform at the level that you&#8217;re supposed to perform to, blaming it on pressure.&#8221;
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
That moment changed O&#8217;Neal&#8217;s perspective. He got out of the car and spoke to the man, who had recently lost his job and was struggling to take care of his wife and two kids. Moved by the encounter, Shaq called a friend and arranged a three-bedroom apartment for the family for $36,000. He also found the man a job through another contact.
Two years later, the man had started his own lawn service business and was cutting Shaq&#8217;s grass in Orlando, Florida.
&#8220;Pressure to me is when you don&#8217;t know where your next meal is coming from,&#8221; O&#8217;Neal told Jimmy Fallon. &#8220;So I don&#8217;t really believe in the word &#8216;pressure&#8217; anymore.&#8221;
See Also: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
<h2 class="wp-block-heading">Putting Family First</h2>
Shaq&#8217;s appreciation for his parents showed up in other major ways. When he signed his first NBA contract in 1992, he didn't just buy them gifts—he <a href="https://www.benzinga.com/24/11/42118033/nba-legend-shaq-put-his-mom-and-dad-on-payroll-when-he-made-it-big-in-basketball-now-you-making-half-a-million-a-year">put them on the payroll</a>.
&#8220;The first thing I did was incorporate &#8216;Shaq,&#8217; and then I put my mom on salary and put my dad on salary,&#8221; he said in a 2022 <a href="https://www.youtube.com/watch?v=RXMpMHPgk7I">interview</a> on &#8220;Drink Champs.&#8221;
His stepfather was earning $60,000 in the Army. Shaq asked him, &#8220;How much you make in the Army?&#8221; When Harrison said the number, Shaq replied, &#8220;Now you making half a million a year.&#8221; Harrison cried.
Shaq asked his mom what she wanted to make and ended up paying her $750,000 annually.
Read Next: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Image: Shutterstock

Shaq's Dad Once Showed Him A Homeless Family And Said: I'm Tired Of You Spoiled, Rich Athletes Who Don't Perform And Blame It On Pressure

Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) on Monday released interim results from the ongoing Phase 2 COURAGE trial.
The company is investigating novel combinations of Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy (semaglutide) (GLP-1 receptor agonist) and trevogrumab (anti-GDF8/anti-myostatin) with or without garetosmab <a href="https://www.benzinga.com/topic/weight-loss" target="_blank" rel="noreferrer noopener">(anti-activin A) for obesity</a>.
The trial demonstrated:
<ul class="wp-block-list">
<li>Approximately 35% of semaglutide-induced weight loss was due to loss of lean mass</li>
<li>Combining semaglutide with trevogrumab with or without garetosmab helped preserve lean mass while <a href="https://www.benzinga.com/pressreleases/25/06/g45717752/interim-results-from-ongoing-phase-2-courage-trial-confirm-potential-to-improve-the-quality-of-sem" target="_blank" rel="noreferrer noopener">increasing loss of fat mass</a>.</li>
<li>Wegovy patients shed about 23 pounds in the study, about 7.9 pounds of which constituted lean mass.</li>
<li>The trevogrumab and low-dose Wegovy combo led to about 21.6 pounds of weight loss, with 3.7 pounds in lean mass.</li>
<li>At a higher dose, the trevogrumab combo therapy showed a weight loss of 24.8 pounds; 4.2 pounds in lean mass.</li>
<li>A triplet combination of semaglutide plus trevogrumab plus garetosmab showed a weight loss of 30 pounds and 2 pounds in lean mass.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45692578/regeneron-sanofi-stock-falls-after-uneven-smokers-lung-drug-data" rel="noreferrer noopener">Regeneron, Sanofi Stock Falls After Uneven Smoker&#8217;s Lung Drug Data</a>
The<a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41208078/regeneron-chief-flags-health-risks-with-popular-weight-loss-medications-like-ozempic-says-company" rel="noreferrer noopener"> combination of semaglutide</a> with trevogrumab was generally well-tolerated; the triplet combination of semaglutide with both antibodies had a substantially higher rate of discontinuations due to tolerability issues and other adverse events, consistent with the safety profile previously seen with garetosmab alone.
After 26 weeks, patients enter into the weight-maintenance phase, receiving either higher-dose trevogrumab monotherapy or a placebo through the end of the trial (week 52).
Data from this phase are not yet available.
Regeneron also announced a strategic in-licensing agreement with Hansoh Pharmaceuticals Group Company Limited. The company acquired clinical development and commercial rights outside the Chinese Mainland, Hong Kong and Macau for a dual GLP-1/GIP receptor agonist <a href="https://www.benzinga.com/pressreleases/25/06/g45717858/regeneron-expands-clinical-stage-obesity-portfolio-with-strategic-in-licensing-of-novel-dual-glp-1" target="_blank" rel="noreferrer noopener">currently in Phase 3 testing</a>.
Therapeutic candidate (HS-20094) – studied in over 1,000 patients and administered weekly subcutaneous injections – has demonstrated promising efficacy and safety clinical data, suggesting a potentially similar profile to the only FDA-approved GLP-1/GIP receptor agonist.
A Phase 3 trial in obesity in China and a Phase 2b study in diabetes are ongoing.
Regeneron will pay Hansoh $80 million upfront. The deal may include additional payments of up to $1.93 billion if certain milestones are achieved.
Potential royalties for global net sales outside designated territories would be in the low double digits.
The company says the complementary asset enables synergy and flexibility across Regeneron&#8217;s broad pipeline of obesity and metabolic programs focused on improved quality of weight loss, co-morbidities, and long-term health.
Price Action: REGN stock is down 0.24% at $489.10 at the last check on Monday
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/hedge-funds/25/06/45725058/loeb-rides-nvidias-ai-wave-bets-big-on-atts-telecom-comeback" target="_blank" rel="noreferrer noopener">Loeb Rides Nvidia&#8217;s AI Wave, Bets Big On AT&amp;T&#8217;s Telecom Comeback</a></li>
</ul>
Image: Shutterstock

Large Cap

Health Care

REGN

Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target

RBC Capital analyst Michael Siperco assumes Artemis Gold (XATS: ARTG) with a Outperform rating and announces Price Target of C$32.

RBC Capital Assumes Artemis Gold at Outperform, Announces Price Target of C$32

SharpLink Gaming Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares are trading lower, pulling back from a strong surge last week. The company on Monday announced the completion of a <a href="https://www.benzinga.com/pressreleases/25/06/g45719444/sharplink-announces-closing-of-425-000-000-private-placement-led-by-consensys-software-inc-will-be">$425 million private placement</a>. 
What Happened: SharpLink Gaming announced the closing of a&nbsp;$425 million&nbsp;private placement led by Consensys Software and other investors. The transaction enables the company to adopt ETH, the native asset of the Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) blockchain, as its primary treasury reserve asset, while continuing to focus on core business operations.
Joseph Lubin, founder and CEO of Consensys and co-founder of Ethereum, became chairman of the company&#8217;s board upon closing of the transaction.
&#8220;We believe that this is a powerful partnership combining SharpLink&#8217;s deep capital markets experience with Consensys&#8217; leadership in both technological innovation and its role in building the Ethereum ecosystem,&#8221; said Rob Phythian, CEO of SharpLink.
The news comes after SharpLink shares soared several hundred percent last week after the company announced plans to adopt an Ethereum <a href="https://www.benzinga.com/pressreleases/25/05/g45615020/sharplink-gaming-announces-425-000-000-private-placement-to-initiate-ethereum-treasury-strategy">treasury strategy</a>. Even with Monday&#8217;s pullback, the stock is still up more than 600% over the past week.
&#8220;This partnership with SharpLink represents more than just a financial milestone: it reflects the growing recognition across capital markets that programmable assets like ETH play an important role today in how value, trust, and financial systems are structured globally,&#8221; Lubin said. 
&#8220;I am pleased to join as Sharplink&#8217;s Chairman of the Board of Directors in adopting Ethereum&#8217;s open, secure, and scalable infrastructure, which is already being used across institutional and decentralized applications.&#8221;&nbsp;&nbsp;&nbsp;
SharpLink is considered a low-float stock with just 659,596 shares available for public trading, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company also had a market cap of approximately $53.5 million as of Friday&#8217;s close.&nbsp;Low-float, micro-cap stocks tend to be very volatile, which may help explain some of the extreme volatility over the past week.
SBET Price Action: <a href="http://benzinga.com/quote/SBET" target="_blank" rel="noreferrer noopener">SharpLink Gaming shares</a> were down 38.1% at $47.49 at the time of publication on Monday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

$ETH

SBET

SharpLink Gaming Stock Is Tumbling Monday: What's Going On?

RBC Capital analyst Michael Siperco maintains i-80 Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/IAU#TSX">IAU</a>) with a Outperform and lowers the price target from C$2 to C$1.5.

TSX:IAU

RBC Capital Maintains Outperform on i-80 Gold, Lowers Price Target to C$1.5

WETO

WETO stock has given up its prior gain. Webush International shares were trading higher after the company announced it signed a $300 million XRP treasury management agreement with Samara Alpha.

<a href="https://www.marijuanamoment.net/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-cannabis-sales-legalization-in-d-c/" title="https://www.marijuanamoment.net/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-cannabis-sales-legalization-in-d-c/">https://www.marijuanamoment.net/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-cannabis-sales-legalization-in-d-c/</a>

Legal

AKAN

CRON

GRWG

IMCC

MAPS

MSOS

SNDL

TLRY

'Trump Wants To Delete State Medical Marijuana Protections From Budget While Continuing To Block Cannabis Sales Legalization In D.C.' - Marijuana Moment

RBC Capital analyst Michael Siperco maintains i-80 Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#AMEX">IAUX</a>) with a Outperform and lowers the price target from $2 to $1.5.

IAUX

RBC Capital Maintains Outperform on i-80 Gold, Lowers Price Target to $1.5

Wells Fargo analyst John Kilichowski maintains Gaming and Leisure Props (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPI#NASDAQ">GLPI</a>) with a Equal-Weight and lowers the price target from $51 to $49.

GLPI

Wells Fargo Maintains Equal-Weight on Gaming and Leisure Props, Lowers Price Target to $49

Fintech

Press Releases

Docusign Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Docusign Appoints Bronwyn Hastings as Group Vice President of Global Partners and Alliances

Identity Fraud Costs Organizations an Average of $7 Million Annually, Says New Research From Docusign and Entrust

Docusign tops Newsweek's list of the Most Trustworthy Software and Telecommunications Companies in America 2025

New Docusign Partner Program to Drive Business Success in the Era of Intelligent Agreement Management

Docusign Ushers in a New Era of AI Contract Agents to Transform Business

Cognizant Expands Partnership with Docusign to Enhance Customer Support and Drive Digital Transformation

Docusign Appoints Michael Adams as New Chief Information Security Officer

Docusign CLM Connector for Coupa Certified as Coupa Total Spend Management Platform Ready

Comments

Docusign

Noticias

Últimas noticias sobre Docusign (NASDAQ:DOCU) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL